UCB has unveiled data from a double-blind, placebo-controlled study, which found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associated with periodic limb movements during ...
Tags: RLS Patients, UCB
St. Jude Medical, a US-based medical device company, has enrolled the first patient for the EnligHTN III trial. During the study, the safety and performance of the second-generation EnligHTN Renal Denervation System in patients with ...
Germany-based Activaero has extended its collaboration agreement with TransMIT, Gesellschaft für Technologietransfer, the technology transfer agency of Justus-Liebig-University Giessen, to develop the treatment of pulmonary ...
Tags: Pulmonary Hypertension, Health
Chinese medicinal cuisine is a long standing tradition. Early records show that it was in use as far back as the Han Dynasty (206 BC - 220). Through continual improvement during succeeding dynasties, it has developed into a practical ...
Tags: Medicinal Food, cuisine
Ventripoint Diagnostics has obtained CE mark certification from European notified body Intertek Semko for its NRV application for the VMS-2DE heart analysis system. The NRV database can be used in conjunction with right heart analysis ...
Tags: Ventripoint, CE Mark, NRV Application
About a third of Americans now have high blood pressure, and nearly two-thirds of those take drugs to control it, according to a new survey by the Centers for Disease Control and Prevention. Our new blood pressure monitor Ratings can help ...
The USFDA has accepted Otsuka Pharmaceutical's new drug application (NDA) of tolvaptan for priority review to treat autosomal dominant polycystic kidney disease (ADPKD). The filing was based on Phase III clinical trial results of the drug ...
Tags: Otsuka Tolvaptan NDA, Medicine
Medtronic has submitted its investigational device exemption (IDE) application to the FDA to initiate a study of its Symplicity renal denervation system for the treatment of uncontrolled hypertension in patients with systolic blood pressure ...
Early phase medical device company ROX Medical has completed enrolling first two Irish patients in a controlled, randomized study of its FLOW procedure for the treatment of resistant hypertension. The FLOW procedure is a minimally ...
Tags: ROX Medical, medical device, Medical
Canadian retailer Loblaw has added lines of "healthier" foods to its flagship own label President's Choice. Loblaw has launched products including cereal, yoghurt and side dishes into the range. "Research shows that eighty-five percent ...
Tags: retailer, Loblaw, healthier foods
St Jude Medical is planning to begin EnligHTNment study, designed to evaluate whether patients with hypertension treated with its EnligHTN renal denervation system can provide additional benefits beyond a reduction in blood pressure. The ...
Tags: Medical, minimally invasive device, EnligHTN
EnteroMedics has reported ReCharge study results of its VBLOC vagal blocking therapy, designed for the treatment of obesity. The pacemaker-like Maestro system delivers VBLOC therapy via two small electrodes that are laparoscopically ...
Applying the same technologies used for voice recognition and credit card fraud detection to medical treatments could cut healthcare costs and improve patient outcomes by almost 50%, according to new research. The research by Indiana ...
Tags: medical treatments, healthcare costs, simulation modeling
Los Angeles-based Targeted Medical Pharma has obtained a notice of issuance for its projected patent number 8370172 from the US Patent and Trademark Office (USPTO). The patent is related to a system and method for submitting claims for a ...
Tags: USPTO, Medical Pharma, patent
VentriPoint Diagnostics has submitted a 510(k) application to the US Food and Drug Administration (FDA) seeking approval for its 2D-ultrasound system, designed for measuring right ventricle heart function in patients with pulmonary arterial ...
Tags: VentriPoint Diagnostics, FDA, pulmonary arterial hypertension